PAR 2.56% 20.0¢ paradigm biopharmaceuticals limited..

Why Zilosul could be a golden goose!!, page-72

  1. 7,675 Posts.
    lightbulb Created with Sketch. 6942
    Said the same myself in prior posts. Its a common assumption on here a deal will only progress on FDA approving the 2x2. I can see numerous scenarios where that is not a factor at all. Its what we want as investors of course. Doesn't make it a pre-requisite to a Chinese deal for example.

    Arguably quite the opposite. If I am a Chinese suitor, convinced of the merits having done my due dilligence already, I want to strike a deal whilst PAR is looking a little listless. If PAR gets 2x2 FDA confirmation, it would be a more brazen PR and co. at the negotiating table.

    Here's hoping Paul "I've been touting a partnership deal for five years" Rennie finally pulls a deal out of the hat, 2x2 FDA confirmation or otherwise.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.